Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 312

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations

Open access
Ybarra, Luiz F., Rinfret, Stéphane, Brilakis, Emmanouil S., Karmpaliotis, Dimitri, Azzalini, Lorenzo, Grantham, J. Aaron, Kandzari, David E., Mashayekhi, Kambis, Spratt, James C., Wijeysundera, Harindra C., Ali, Ziad A., Buller, Christopher E., Carlino, Mauro, Cohen, David J., Cutlip, Donald E., De Martini, Tony, Di Mario, Carlo, Farb, Andrew, Finn, Aloke V., Galassi, Alfredo R., Gibson, C. Michael, Hanratty, Colm, Hill, Jonathan M., Jaffer, Farouc A., Krucoff, Mitchell W., Lombardi, William L., Maehara, Akiko, Magee, P.F. Adrian, Mehran, Roxana, Moses, Jeffrey W., Nicholson, William J., Onuma, Yoshinobu, Sianos, Georgios, Sumitsuji, Satoru, Tsuchikane, Etsuo, Virmani, Renu, Walsh, Simon J., Werner, Gerald S., Yamane, Masahisa, Stone, Gregg W., Rinfret, Stéphane, Stone, Gregg W., On behalf of the Chronic Total Occlusion Academic Research Consortium·2021·Circulation

Abstract

Over the past 2 decades, chronic total occlusion (CTO) percutaneous coronary intervention has developed into its own subspecialty of interventional cardiology. Dedicated terminology, techniques, devices, courses, and training programs have enabled progressive advancements. However, only a few randomized trials have been performed to evaluate the safety and efficacy of CTO percutaneous coronary intervention. Moreover, several published observational studies have shown conflicting data. Part of the paucity of clinical data stems from the fact that prior studies have been suboptimally designed and performed. The absence of standardized end points and the discrepancy in definitions also prevent consistency and uniform interpretability of reported results in CTO intervention. To standardize the field, we therefore assembled a broad consortium comprising academicians, practicing physicians, researchers, medical society representatives, and regulators (US Food and Drug Administration) to develop methods, end points, biomarkers, parameters, data, materials, processes, procedures, evaluations, tools, and techniques for CTO interventions. This article summarizes the effort and is organized into 3 sections: key elements and procedural definitions, end point definitions, and clinical trial design principles. The Chronic Total Occlusion Academic Research Consortium is a first step toward improved comparability and interpretability of study results, supplying an increasingly growing body of CTO percutaneous coronary intervention evidence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.120.046754

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Metadata

Authors
Ybarra, L. F., Rinfret, S., Brilakis, E. S., Karmpaliotis, D., Azzalini, L., Grantham, J. A., Kandzari, D. E., Mashayekhi, K., Spratt, J. C., Wijeysundera, H. C., Ali, Z. A., Buller, C. E., Carlino, M., Cohen, D. J., Cutlip, D. E., De Martini, T., Di Mario, C., Farb, A., Finn, A. V., Galassi, A. R., Gibson, C. M., Hanratty, C., Hill, J. M., Jaffer, F. A., Krucoff, M. W., Lombardi, W. L., Maehara, A., Magee, P. F. A., Mehran, R., Moses, J. W., Nicholson, W. J., Onuma, Y., Sianos, G., Sumitsuji, S., Tsuchikane, E., Virmani, R., Walsh, S. J., Werner, G. S., Yamane, M., Stone, G. W., Rinfret, S., Stone, G. W., & On behalf of the Chronic Total Occlusion Academic Research Consortium
Venue
Circulation
Published
2021-02-02
Volume
143
Issue
5
Pages
479-500
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W3127991899
Cited by
312
References
50
FWCI
41.73
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations. https://app.cochat.ai/papers/10.1161/circulationaha.120.046754
The paper
Ybarra, L. F., Rinfret, S., Brilakis, E. S., Karmpaliotis, D., Azzalini, L., Grantham, J. A., Kandzari, D. E., Mashayekhi, K., Spratt, J. C., Wijeysundera, H. C., Ali, Z. A., Buller, C. E., Carlino, M., Cohen, D. J., Cutlip, D. E., De Martini, T., Di Mario, C., Farb, A., Finn, A. V., . . . On behalf of the Chronic Total Occlusion Academic Research Consortium. (2021). Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations. Circulation. https://doi.org/10.1161/circulationaha.120.046754

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.